Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularLMAT +0.78%100 Days Payable is 17.25 as of Jun. 2026, which is 1% below its 10-year median of 17.42. GuruFocus rates LMAT with a GF Score™ of 100/100 and a GF Value™ of $95.26 (Modestly Undervalued). Among 795 Medical Devices & Instruments companies, LeMaitre Vascular ranks worse than 93.46% on this metric.
The historical rank and industry rank for LeMaitre Vascular's Days Payable or its related term are showing as below:
LMAT'
s Days Payable Range Over the Past 10 Years
Min: 13.89 Med: 17.42 Max: 21.17
Current: 19.95
During the past 13 years, LeMaitre Vascular's highest Days Payable was 21.17. The lowest was 13.89. And the median was 17.42.
LMAT's Days Payable is ranked worse than 93.46% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.21
vs LMAT: 19.95
LeMaitre Vascular's Days Payable
increased
from Jun. 2025 (16.81) to Jun. 2026 (17.25).
It may suggest that LeMaitre Vasculardelayed paying its suppliers.
The historical data trend for LeMaitre Vascular's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Days Payable distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
LeMaitre Vascular's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (LMAT) has a Days Payable of 17.25 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on LeMaitre Vascular and its competitors. This is near median its historical median of 17.42. Over the past decade, LeMaitre Vascular's Days Payable has ranged from 13.89 to 21.17. According to the industry distribution chart, LeMaitre Vascular ranks #743 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 93.5%.
Is LeMaitre Vascular's Days Payable too high?
LeMaitre Vascular's current Days Payable of 17.25 is near median its 10-year median of 17.42. Over the past 10 years, this metric has ranged from a low of 13.89 to a high of 21.17. The Medical Devices & Instruments industry median Days Payable is 68.21. LeMaitre Vascular's value of 17.25 is 74.7% below this industry median. Based on the distribution chart, LeMaitre Vascular ranks #743 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Days Payable compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #743 out of 795 companies for Days Payable. This places LeMaitre Vascular in the lower half of its industry. The industry median Days Payable is 68.21. LeMaitre Vascular's value of 17.25 is 74.7% below this benchmark. Historically, LeMaitre Vascular's own Days Payable has ranged from 13.89 to 21.17 over the past decade. While the company's 10-year median is 17.42 vs. the industry median of 68.21, LeMaitre Vascular has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.21, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current Days Payable of 17.25 is 74.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current Days Payable is 17.25, which is near median its own 10-year median of 17.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (LMAT) is currently considered Modestly Undervalued. The stock's GF Value™ is $95.26, compared to a current price of $81.45 — trading 14.5% below its estimated fair value. The current Days Payable is 17.25, which is near median its 10-year median of 17.42 and 74.7% below the Medical Devices & Instruments industry median of 68.21. LeMaitre Vascular's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For LeMaitre Vascular (LMAT), the current Days Payable is 17.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (LMAT) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of $81.45 is trading 14.5% below its estimated GF Value™ of $95.26.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for LMAT:
Days Payable: 17.25 (near median its 10-year median of 17.42)
GF Value™: $95.26 vs. price of $81.45 (14.5% below fair value)
Industry Position: 74.7% below the Medical Devices & Instruments median (#743 of 795)
No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
100GF Score
Get the complete analysis for LMAT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMAT has been successfully added to your 
